HC
Senhwa Biosciences Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Silmitasertib (CX-4945) | Cholangiocarcinoma | Phase II |
| Pidnarulex (CX-5461) | Solid Tumors with HRD | Phase I |
| Drug | Indication | Phase |
|---|---|---|
| Silmitasertib (CX-4945) | Cholangiocarcinoma | Phase II |
| Pidnarulex (CX-5461) | Solid Tumors with HRD | Phase I |